capillary electrophoresis
Sysmex, Hitachi High-Tech to Develop Low-Cost CE Sequencers for Genetic Testing
The Japanese firms plan to apply their technologies toward the development of capillary electrophoresis sequencing-based testing systems for use in oncology and other diseases.
Swift Biosciences, BillionToOne Partner to Commercialize COVID-19 Test
BillionToOne's assay detects SARS-CoV-2 in samples from nasal, nasopharyngeal, and oropharyngeal swabs and has a testing capacity of 1 million tests per day.
DxTerity Diagnostics, Patients Choice Get FDA Emergency Use Authorizations for Coronavirus Tests
The two tests, both of which use RT-PCR technology to detect multiple viral targets, may be performed only by their respective developers.
Asuragen Fragile X Diagnostic Test Gets FDA Authorization
The firm's AmplideX Fragile X Dx and Carrier Screen Kit is intended to help diagnose fragile X syndrome and assess parental risk of having a child with the syndrome.